Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions
Kircher, Moritz F.
Swirski, Filip K.
Gerszten, Robert E.
Allport, Jennifer R.
MetadataShow full item record
CitationKircher, Moritz F., Jan Grimm, Filip K. Swirski, Peter Libby, Robert E. Gerszten, Jennifer R. Allport, and Ralph Weissleder. 2008. “Noninvasive In Vivo Imaging of Monocyte Trafficking to Atherosclerotic Lesions.” Circulation 117 (3): 388–95. https://doi.org/10.1161/circulationaha.107.719765.
AbstractBackground-Monocytes play a key role in atherogenesis, but their participation has been discerned largely via ex vivo analyses of atherosclerotic lesions. We sought to establish a noninvasive technique to determine monocyte trafficking to atherosclerotic lesions in live animals. Methods: and Results-Using a micro-single-photon emission computed tomography small-animal imaging system and a Food and Drug Administration-approved radiotracer ([ indium 111] oxyquinoline, In-111-oxine), we demonstrate here that monocyte recruitment to atherosclerotic lesions can be visualized in a noninvasive, dynamic, and 3-dimensional fashion in live animals. We show in vivo that monocytes are recruited avidly to plaques within days of adoptive transfer. Using micro-single-photon emission computed tomography imaging as a screening tool, we were able to investigate modulatory effects on monocyte recruitment in live animals. We found that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors rapidly and substantially reduce monocyte recruitment to existing atherosclerotic lesions, as imaged here in vivo. Conclusions: -This novel approach to track monocytes to atherosclerotic plaques in vivo should have broad applications and create new insights into the pathogenesis of atherosclerosis and other inflammatory diseases.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41384403
- HMS Scholarly Articles 
Contact administrator regarding this item (to report mistakes or request changes)